The development of AI humanoid welding robots continues to gain momentum as HD Hyundai and its partners expand collaboration on advanced robotic solutions for shipyard operations. The latest initiative highlights ongoing efforts to commercialize intelligent welding systems designed for demanding industrial environments while supporting future manufacturing automation in Korea. Robots usually require KCs certification in order to be approved for import and sale in Korea.

HD Hyundai announced that its affiliates, HD Korea Shipbuilding & Offshore Engineering (KSOE) and HD Hyundai Robotics, have entered into a partnership with Persona AI, a Houston-based robotics company specializing in humanoid platforms. The agreement builds upon a memorandum of understanding signed in May of the previous year to advance humanoid robots for welding operations in shipyards.
According to the announcement, development work carried out since last year has already produced a prototype that demonstrates promising technical feasibility. The new cooperation assigns specific responsibilities to each participant. HD KSOE will develop robot welding training technologies using operational data collected from shipyards, helping improve the performance of AI-driven welding systems. HD Hyundai Robotics will be responsible for integrating the robotic systems for deployment in industrial environments, while Persona AI will develop a bipedal humanoid platform capable of stable movement across the complex terrain typically found in shipyards.
The long-term objective is the gradual introduction of specialized humanoid welding robots that can perform complex welding tasks at operational shipbuilding facilities.
As development progresses from prototype validation toward commercial implementation, manufacturers must also consider regulatory compliance requirements before placing robotic equipment on the Korean market. Industrial robots and related electrical or electronic equipment may be subject to applicable Korean technical regulations depending on their design, intended use, electrical characteristics, and associated safety functions.
For products falling within the relevant scope, KCs certification serves as an important conformity assessment framework supporting compliance with applicable Korean safety requirements before products can be marketed or placed into service. Companies introducing AI-enabled industrial robotics should therefore evaluate certification obligations early in the product development process to avoid delays during commercialization.
The collaboration demonstrates how advances in artificial intelligence, robotics integration, and industrial automation are increasingly being combined to address labor-intensive manufacturing activities. For exporters, manufacturers, and technology developers targeting the Korean market, aligning product development with applicable regulatory and certification requirements remains an essential part of successful market access. Further regulatory information may be available through official certification resources and industry regulatory news.
Feel free to contact us any time if you need assistance or have any questions regarding Korean certifications like KC, KC EMC, KCs, KCs for explosion safety products, KGS factory registration and MFDS for medical devices.
Tel. Europe: +49-69-271 37 69 259
Tel. US: +1 773 654-2673
Email: info@korea-certification.com
For more information you can download our free brochure “Korea Certification Made Easy – The Booklet“.
South Korea is accelerating the adoption of AI healthcare systems by investing in new technologies across regional hospitals. The latest government initiative supports the deployment of AI healthcare systems that enhance diagnosis, improve patient monitoring, and reduce administrative workloads, strengthening healthcare services throughout the country.
The Ministry of Health and Welfare announced that it will allocate 12 billion won to regional responsible medical institutions as part of its AI-based care system support program. The funding aims to introduce practical artificial intelligence solutions that improve medical capabilities while helping healthcare professionals focus more on patient treatment instead of routine documentation. AI healthcare systems usually require MFDS certification in order to be approved for import and sale in Korea.

Several national university hospitals will implement AI technologies designed to improve patient outcomes through earlier detection of critical conditions. Chungbuk National University Hospital and Pusan National University Hospital will deploy AI systems that continuously analyze inpatient vital signs to predict life-threatening events such as cardiac arrest and sepsis, enabling faster clinical intervention.
Additional projects focus on medical imaging. Chonbuk National University Hospital and Pusan National University Hospital will introduce AI-assisted diagnostic support capable of identifying suspected lung disease and cancer by analyzing chest X-rays and computed tomography (CT) images. These systems are intended to improve the accuracy and efficiency of clinicians’ image interpretation while supporting earlier identification of serious illnesses.
Other participating institutions will deploy specialized AI applications. Gyeongsang National University Hospital plans to implement AI for the early diagnosis of stroke and dementia, while Jeju National University Hospital will use AI to evaluate coronary artery stenosis from chest CT images, supporting the assessment of cardiovascular disease risk.
The initiative also includes AI tools that streamline clinical documentation. Chonnam National University Hospital, Chungnam National University Hospital, and Chonbuk National University Hospital will introduce AI-powered medical record systems capable of automatically generating clinical notes from spoken conversations between healthcare professionals and patients. By reducing administrative burdens, these solutions allow medical staff to devote more time to direct patient care.
According to the Ministry of Health and Welfare, expanding AI adoption is intended to strengthen healthcare capabilities at regional medical institutions while improving access to advanced diagnostic and patient management technologies. The program reflects South Korea’s broader strategy of integrating artificial intelligence into clinical practice to support earlier diagnosis, emergency response, and more efficient healthcare delivery. Further regulatory information may be available through official MFDS and government healthcare resources.
Feel free to contact us any time if you need assistance or have any questions regarding Korean certifications like KC, KC EMC, KCs, KCs for explosion safety products, KGS factory registration and MFDS for medical devices.
Tel. Europe: +49-69-271 37 69 259
Tel. US: +1 773 654-2673
Email: info@korea-certification.com
For more information you can download our free brochure “Korea Certification Made Easy – The Booklet“.
South Korea is taking a significant step toward expanding its hydrogen infrastructure through a new government-backed research project focused on large-scale liquid hydrogen storage systems. The initiative centers on the development of advanced liquid hydrogen storage technology, a key component for supporting the country’s growing hydrogen economy and future energy transition goals.
Hyundai Engineering & Construction (Hyundai E&C) announced that it has been selected to participate in a national research and development project led by the Korea Agency for Infrastructure Technology Advancement under the Ministry of Land, Infrastructure and Transport. The project aims to secure essential technologies for liquid hydrogen storage, transfer, and unloading systems required for future hydrogen receiving terminals, while also validating these technologies through demonstration activities. Hydrogen storage systems usually require KGS certification in order to be approved for import and sale in Korea.

A major objective of the project is the development of South Korea’s first flat-bottom liquid hydrogen storage tank. This storage concept, commonly used in large-scale LNG applications, is expected to provide a foundation for future expansion to storage capacities of approximately 4,000 cubic meters and eventually 50,000 cubic meters.
The government-funded project has a budget of approximately KRW 29 billion and will run for around 45 months from April 2026 through December 2029. Hyundai E&C will collaborate with 13 additional industry, academic, and research organizations, including Korea Gas Corporation, Korea Gas Technology Corporation, and Korea Gas Safety Corporation.
Liquid hydrogen is produced by cooling gaseous hydrogen to approximately -253°C, requiring highly sophisticated insulation, structural engineering, and construction technologies to maintain cryogenic conditions. As part of the project, participants will develop metal material property databases, structural and insulation design technologies, thermal transfer and fluid flow analysis methods, and engineering design criteria for liquid hydrogen storage facilities.
The project also includes the construction and demonstration of a 200-cubic-meter storage tank to evaluate storage performance, reduce boil-off gas generation, and strengthen safety technologies. These developments are expected to support future regulatory frameworks and technical requirements applicable to hydrogen storage infrastructure in Korea.
For manufacturers, engineering companies, and infrastructure developers, the initiative signals growing regulatory and technical attention toward liquid hydrogen technologies. As hydrogen demand increases, compliance with relevant Korean safety standards and certification requirements, including KGS-related provisions where applicable, will become increasingly important for market participation.
Hyundai E&C stated that while global and domestic hydrogen markets continue to expand, liquid hydrogen technology remains at an early stage of development. The company expects the project to contribute to greater technological independence in the liquid hydrogen sector, reduce reliance on overseas technologies, and strengthen the competitiveness of Korea’s hydrogen infrastructure and plant engineering industries. Further regulatory and certification updates may become available through official industry and certification news resources.
Feel free to contact us any time if you need assistance or have any questions regarding Korean certifications like KC, KC EMC, KCs, KCs for explosion safety products, KGS factory registration and MFDS for medical devices.
Tel. Europe: +49-69-271 37 69 259
Tel. US: +1 773 654-2673
Email: info@korea-certification.com
For more information you can download our free brochure “Korea Certification Made Easy – The Booklet“.
South Korea is advancing the adoption of hydrogen forklifts through a new support initiative in Jeju Province, reinforcing efforts to reduce emissions from industrial and construction equipment. The program forms part of a broader transition toward zero-emission machinery and is designed to lower particulate matter and greenhouse gas emissions while improving the carbon footprint of worksite operations.
Jeju Province announced that it will allocate approximately KRW 420 million in 2026 to support the purchase of 12 zero-emission forklifts, including two hydrogen-powered units and ten electric models. The selected applicants will receive financial assistance based on the order in which applications are submitted. Hydrogen drives as used for such forklifts usually require KGS certification in order to be approved for import and sale in Korea.

Under the program, two 3-ton hydrogen forklift models manufactured by Doosan Bobcat Korea are eligible for support. Each hydrogen forklift can receive a subsidy of approximately KRW 160 million. According to the announcement, only ten hydrogen forklifts have previously been deployed nationwide, including units supplied in Incheon, Chungju, and Ulsan, highlighting the early stage of market adoption.
The electric forklift segment covers 29 eligible models ranging from 2.5-ton to 9-ton capacity. These models are supplied by HD Hyundai Site Solutions and Clark Material Handling Asia. Depending on the specific model, financial support ranges from approximately KRW 4 million to KRW 25 million per unit.
Eligible models and subsidy levels can be verified through Korea’s integrated zero-emission vehicle information platform. Applications for purchase support must be submitted through the relevant manufacturer or importer when acquiring approved zero-emission construction machinery.
The Jeju initiative reflects South Korea’s wider policy objective of replacing conventional internal-combustion equipment with cleaner alternatives. As authorities continue promoting hydrogen technologies and electrification across industrial sectors, manufacturers and importers of material-handling equipment may encounter increasing opportunities in the Korean market.
For hydrogen-powered forklifts, compliance with applicable Korean safety and technical requirements remains an important consideration. KGS certification, where required, plays a key role in demonstrating conformity with national gas safety regulations and supporting market access for hydrogen-related equipment.
Jeju officials stated that the province is pursuing a dual strategy of applying emission-reduction measures to existing equipment while accelerating the adoption of zero-emission machinery for new deployments. The program also supports the province’s long-term vision of achieving a low-carbon environment and improving local air quality through expanded use of clean industrial technologies.
Feel free to contact us any time if you need assistance or have any questions regarding Korean certifications like KC, KC EMC, KCs, KCs for explosion safety products, KGS factory registration and MFDS for medical devices.
Tel. Europe: +49-69-271 37 69 259
Tel. US: +1 773 654-2673
Email: info@korea-certification.com For more information you can download our free brochure “Korea Certification Made Easy – The Booklet
South Korea’s Ministry of Food and Drug Safety (MFDS) has ordered a temporary sales suspension for two anti-inflammatory painkillers produced by Korea Syntex Pharmaceutical following violations related to product labeling requirements. The regulatory action highlights the importance of MFDS compliance for pharmaceutical manufacturers seeking to maintain market access in Korea. Medical products usually require MFDS certification in order to be approved for import and sale in Korea.

According to the MFDS, the affected products are Ifpen tablets and Ifpen W tablets. The authority stated that the labeling displayed on the product containers differed from the approved or officially filed information. As a result, the company received an administrative disposition on April 27, with the three-month suspension period remaining in effect until July 9.
The latest enforcement action follows a series of previous regulatory violations involving Korea Syntex Pharmaceutical. In December of last year, the company received another administrative disposition for failing to comply with Good Manufacturing Practice (GMP) requirements. The MFDS identified several deficiencies, including the failure to conduct raw material quality testing, insufficient validation of cleaning procedures based on the company’s own manuals, and the absence of required stability testing.
As part of that earlier case, manufacturing operations for 58 pharmaceutical items were suspended for periods ranging from three to four months. The repeated violations have drawn attention to the stricter enforcement environment surrounding pharmaceutical manufacturing and quality management in South Korea.
The MFDS continues to strengthen oversight of pharmaceutical production processes as part of broader efforts to ensure product safety, manufacturing consistency, and accurate labeling within the domestic healthcare market.
Korea Syntex Pharmaceutical has also faced previous sanctions related to unauthorized formulation changes. In November 2023, regulators found that the company had added an excipient during manufacturing without approval, leading to the cancellation of its GMP compliance determination. A second cancellation occurred in April 2024 after the company was found to have changed an excipient without submitting the required change report to regulators.
The company challenged the administrative measures through legal proceedings but ultimately lost in the first trial and later accepted the ruling.
The case underscores the importance of maintaining accurate product registration details, validated manufacturing procedures, and strict GMP compliance under South Korea’s pharmaceutical regulatory framework. Manufacturers exporting or producing medical products for the Korean market may face administrative penalties, production suspensions, or certification cancellations if they fail to comply with MFDS filing and quality requirements.
Further regulatory developments may continue to influence compliance expectations for pharmaceutical companies operating in Korea’s regulated healthcare sector.
Feel free to contact us any time if you need assistance or have any questions regarding Korean certifications like KC, KC EMC, KCs, KCs for explosion safety products, KGS factory registration and MFDS for medical devices.
Tel. Europe: +49-69-271 37 69 259
Tel. US: +1 773 654-2673
Email: info@korea-certification.com
For more information you can download our free brochure “Korea Certification Made Easy – The Booklet“.
The rapid expansion of oral obesity treatments is drawing increased regulatory attention, particularly under the Korea MFDS framework governing pharmaceutical approvals. As global pharmaceutical companies shift from injectable to oral formulations, the Korea MFDS regulatory pathway is expected to play a critical role in determining how quickly these innovative therapies enter the domestic market. Korean developers are actively aligning their research and commercialization strategies with evolving international and local compliance requirements. Pharmaceutical products usually require MFDS approval in order to be approved for import and sale in Korea.

The growing interest in glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide and orforglipron, reflects a broader trend toward more convenient, patient-friendly drug delivery methods. Oral formulations eliminate the need for cold-chain logistics and injections, which can simplify distribution and improve patient adherence. However, these advantages also require thorough regulatory evaluation to ensure safety, efficacy, and quality standards are met before market entry.
Internationally, leading products such as Novo Nordisk’s Wegovy tablets and Eli Lilly’s Foundayo have already received approval in the United States, demonstrating strong clinical performance in weight reduction. As these products expand into global markets, manufacturers must navigate country-specific regulatory frameworks, including Korea’s MFDS requirements for clinical data, manufacturing standards, and labeling compliance.
In Korea, regulatory authorities have also intensified oversight in response to concerns about counterfeit or improperly marketed weight loss products. This has led to stricter enforcement actions and greater scrutiny of health claims, particularly in the dietary supplement and pharmaceutical sectors. For companies seeking MFDS certification, this environment underscores the importance of robust clinical evidence and transparent product positioning.
At the same time, Korean pharmaceutical companies are pursuing differentiated approaches to obesity treatment development. These include injectable therapies tailored to local patient populations, oral drug candidates advancing through clinical trials, and alternative delivery systems such as transdermal patches. Next-generation products, including multi-action and small-molecule GLP-1 therapies, are also under development, reflecting efforts to enhance efficacy and patient convenience while meeting regulatory expectations.
The global obesity treatment market has seen significant growth, driven by rising prevalence rates and increased demand for effective therapies. For Korean companies, expanding into international markets requires not only meeting MFDS standards but also aligning with regulatory requirements in other jurisdictions. Conversely, foreign manufacturers aiming to enter Korea must prepare for MFDS review processes, which may include additional data submissions and local clinical considerations.
As oral obesity treatments continue to gain traction, regulatory compliance will remain a key factor influencing market access and product success. The Korea MFDS is expected to maintain a central role in evaluating these therapies, balancing innovation with patient safety. Further regulatory updates and guidance may be available through official certification resources and industry publications.
Feel free to contact us any time if you need assistance or have any questions regarding Korean certifications like KC, KC EMC, KCs, KCs for explosion safety products, KGS factory registration and MFDS for medical devices.
Tel. Europe: +49-69-271 37 69 259
Tel. US: +1 773 654-2673
Email: info@korea-certification.com
LG CNS introduced a cold-chain logistics automation system capable of operating at temperatures as low as minus 26 degrees Celsius, targeting expanded adoption in North America’s temperature-controlled supply chain sector. The Mobile Shuttle robot system was unveiled at Modex 2026 in Atlanta, a major industry exhibition. Engineered for subzero environments, the solution is intended for applications in food distribution and retail logistics, where consistent performance under extreme conditions is critical. Robotic products and components usually require KCs or KC EMC certification to be approved for import and sale in Korea.

The system deploys fleets ranging from dozens to hundreds of robots that navigate warehouse racks at speeds of up to 1.5 meters per second, each supporting loads of up to 1,500 kilograms. Its four-directional shuttle design allows horizontal and vertical movement, reducing routing constraints and improving operational flexibility. LG CNS reports over 30 percent higher storage efficiency compared to conventional systems, supported by high-density configurations. Integrated AI capabilities enable natural language control via chatbot interfaces, real-time diagnostics, and operational recommendations. The solution also supports diverse cargo types, including cylindrical goods such as electric vehicle batteries, while mathematical optimization tools enhance routing and throughput. The company has already deployed the system in North American facilities, including a recent installation at a bakery production site in Texas.
Feel free to contact us any time if you need assistance or have any questions regarding Korean certifications like KC, KC EMC, KCs, KCs for explosion safety products or KGS factory registration.
Tel. Europe: +49-69-271 37 69 259
Tel. US: +1 773 654-2673
Email: info@korea-certification.com
For more information you can download our free brochure “Korea Certification Made Easy – The Booklet“.
JW Pharmaceutical has entered into a licensing agreement with China-based Gan & Lee Pharmaceuticals to obtain exclusive rights in Korea for bofanglutide, an advanced GLP-1 receptor agonist. Under the terms of the deal, JW Pharmaceutical will oversee clinical development, regulatory submissions, and commercialization within the Korean market, while Gan & Lee will supply the necessary data and documentation to support investigational new drug applications and product approvals. The total agreement value may reach $81.1 million, including an upfront payment of $5 million and additional milestone-based payments linked to approvals across multiple indications. Medical products usually require MFDS certification in order to be approved for import and sale in Korea.

The drug has demonstrated promising outcomes in clinical studies, including a Phase 2b trial where patients achieved an average weight reduction of 17.3 percent over 30 weeks with biweekly administration. JW Pharmaceutical plans to initiate Phase 3 trials in Korea later this year, targeting obesity and type 2 diabetes. The partnership aligns with growing global and regional demand for GLP-1 therapies, with the Asia-Pacific market projected to expand significantly in the coming years. Both companies emphasized that the collaboration will support the advancement of innovative treatments and broaden access to new therapeutic options in Korea.
Feel free to contact us any time if you need assistance or have any questions regarding Korean certifications like KC, KC EMC, KCs, KCs for explosion safety products, MFDS certification for medical products or KGS factory registration.
Tel. Europe: +49-69-271 37 69 259
Tel. US: +1 773 654-2673
Email: info@korea-certification.com
For more information you can download our free brochure “Korea Certification Made Easy – The Booklet“.
Korea’s KC Safety certification framework for heavy machinery and components is drawing increased attention as Korea Zinc advances a major domestic strategic minerals initiative. The company’s planned investment of 11 trillion won in a new smelter project highlights broader regulatory considerations for manufacturers operating within Korea, particularly those supplying equipment to large-scale industrial developments.

Korea Zinc has launched its “Crucible Zinc” project in the Ulsan industrial hub, where it intends to build a large smelting facility by 2029. The plant is expected to produce a diverse range of non-ferrous metals, including critical minerals used in advanced manufacturing, as well as semiconductor-grade materials. Given the project’s scale and technical complexity, compliance requirements for heavy machinery and industrial components are becoming more demanding. In Korea, such equipment generally requires KC Safety certification before it can be deployed or distributed.
KC Safety Certification Framework for Industrial Equipment
KC Safety certification is a mandatory conformity assessment system in Korea that applies to a wide spectrum of industrial and electrical products, including heavy machinery and related components. Its purpose is to ensure that products meet national standards for safety, electromagnetic compatibility, and performance prior to market entry or operational use.
For suppliers involved in large industrial projects—such as smelting, mining, or recycling operations—KC certification may be required for equipment including lifting systems, processing machinery, and electrical control units. The certification process typically involves product testing, factory inspections, and documentation review conducted by authorized Korean institutions. As industrial systems become more advanced, certification requirements may also extend to integrated technologies and complex processing systems.
Market Access and Compliance Considerations
The expansion of advanced smelting infrastructure within South Korea reflects a broader push to secure critical mineral supply chains and enhance industrial resilience. For companies supplying machinery and components domestically, this reinforces the need to address KC Safety requirements early in product design and project planning.
Manufacturers must ensure compliance with Korean standards, especially when providing equipment for high-risk environments such as metal processing or chemical handling. Without proper certification, companies may face project delays, regulatory penalties, or additional costs.
Additionally, the growing focus on recycling and recovery of rare metals—such as Germanium, Gallium, and Indium—introduces further technical considerations that can affect certification scope. Equipment used in these processes must meet strict safety and reliability expectations under Korean regulations.
As domestic industrial projects continue to scale and supply chains become more interconnected, regulatory compliance remains a key factor in ensuring smooth market access and operational readiness.
Feel free to contact us any time if you need assistance or have any
questions regarding Korean certifications like KC, KC EMC, KCs, KCs for explosion safety products or KGS factory registration.
Tel. Europe: +49-69-271
37 69 259
Tel. US: +1 773 654-2673
Email: info@korea-certification.com
South Korea is advancing its hydrogen mobility ecosystem with new infrastructure aligned with KGS certification requirements, as demonstrated by the completion of a liquefied hydrogen charging station at Incheon International Airport. The project reflects the country’s broader regulatory and safety framework governing hydrogen storage, transport, and refueling systems under the Korea Gas Safety (KGS) certification scheme.

The newly completed station, developed by SK Innovation E&S, is located within the Terminal 2 parking area and is designed to supply up to 320 kilograms of liquefied hydrogen per hour. This capacity enables the daily refueling of up to 240 hydrogen-powered buses, supporting high-frequency airport operations. The facility is supplied by a nearby liquefied hydrogen production plant in Incheon, which produces approximately 90 tons per day. Hydrogen refueling infrastructure usually requires KGS certification in order to be approved for import and sale in Korea.
KGS certification plays a critical role in ensuring the safety and compliance of hydrogen-related installations in South Korea. The certification framework covers the design, construction, inspection, and operation of high-pressure gas systems, including liquefied hydrogen production plants and refueling stations. Facilities must comply with stringent technical standards addressing pressure control, cryogenic storage, leak prevention, and emergency response systems.
In the case of the Incheon airport station, compliance with KGS standards would have been essential throughout the project lifecycle, from engineering design to final commissioning. The integration of liquefied hydrogen systems introduces additional technical considerations compared to gaseous hydrogen, including ultra-low temperature handling and specialized insulation requirements.
The project also highlights the role of public-private cooperation in advancing compliant hydrogen infrastructure. Government funding and oversight, combined with private sector investment, support adherence to national safety codes while accelerating deployment timelines.
The deployment of hydrogen refueling infrastructure at a major international airport signals increasing maturity in Korea’s hydrogen mobility strategy. For manufacturers and operators, compliance with KGS certification remains a prerequisite for market entry, particularly for equipment such as storage tanks, dispensers, and transport systems.
The introduction of hydrogen-powered buses at Incheon Airport—already replacing a significant portion of the existing fleet—demonstrates the operational viability of such systems under regulatory oversight. Hydrogen buses offer advantages in refueling time and driving range, making them suitable for high-demand transport environments.
From a regulatory perspective, the visibility of such projects reinforces Korea’s commitment to carbon neutrality while emphasizing the importance of certified infrastructure. Companies seeking to participate in Korea’s hydrogen economy must ensure that their technologies meet KGS requirements to facilitate approval and deployment.
Further regulatory updates and technical guidance may be available through official certification bodies and industry resources.
Feel free to contact us any time if you need assistance or have any questions regarding Korean certifications like KC, KC EMC, KCs, KCs for explosion safety products or KGS factory registration.
Tel. Europe: +49-69-271 37 69 259
Tel. US: +1 773 654-2673
Email: info@korea-certification.com
For more information you can download our free brochure “Korea Certification Made Easy – The Booklet“.
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information